These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 34742383)
1. A high prostatic-specific antigen with a large pelvic mass indicates a prostatic cystadenocarcinoma. Di Maida F; Grosso AA; Crisci A; Mari A; Carini M; Minervini A Lancet; 2021 Nov; 398(10312):1726. PubMed ID: 34742383 [No Abstract] [Full Text] [Related]
2. Papillary cystadenocarcinoma of the prostate. Mandel E; Yeh H; Schapira HE J Urol; 1984 May; 131(5):972-4. PubMed ID: 6708240 [TBL] [Abstract][Full Text] [Related]
3. Papillary cystoadenocarcinoma of the prostate. Takeuchi S; Higashi Y; Kobayashi I; Takahama M Hinyokika Kiyo; 1992 Mar; 38(3):347-9. PubMed ID: 1381865 [TBL] [Abstract][Full Text] [Related]
4. The quest for the perfect prostate biopsy continues. Gomella LG J Urol; 2012 Jun; 187(6):1954-5. PubMed ID: 22503025 [No Abstract] [Full Text] [Related]
6. [Clinical and histopathological characteristics of nonpalpable prostatic carcinoma]. Landmann C Strahlenther Onkol; 1995 Mar; 171(3):174-5. PubMed ID: 7535953 [No Abstract] [Full Text] [Related]
7. [Current status of echoguided transrectal biopsy of the prostate gland]. Herranz Amo F Actas Urol Esp; 1998 Jun; 22(6):461-71. PubMed ID: 9734121 [No Abstract] [Full Text] [Related]
8. Novel biomarkers and advanced imaging modalities in the early detection of prostate cancer. Parsons JK J Urol; 2015 Apr; 193(4):1084-5. PubMed ID: 25596362 [No Abstract] [Full Text] [Related]
9. Spectrum of Cystic Epithelial Tumors of the Prostate: Most Cystadenocarcinomas Are Ductal Type With Intracystic Papillary Pattern. Paner GP; Lopez-Beltran A; So JS; Antic T; Tsuzuki T; McKenney JK Am J Surg Pathol; 2016 Jul; 40(7):886-95. PubMed ID: 26900818 [TBL] [Abstract][Full Text] [Related]
10. Repeating the measurement of prostate-specific antigen in symptomatic men can avoid unnecessary prostatic biopsy. Mishra VC; Motiwala HG BJU Int; 2004 May; 93(7):1116-7. PubMed ID: 15142181 [No Abstract] [Full Text] [Related]
11. Extraprostatic papillary cystadenocarcinoma of the prostate. Kajbafzadeh AM; Djaladat H South Med J; 2006 Nov; 99(11):1285-6. PubMed ID: 17195426 [TBL] [Abstract][Full Text] [Related]
12. The interplay between obesity and the accuracy of prostate-specific antigen (PSA) for predicting prostate cancer. Granieri MA; Freedland SJ BJU Int; 2013 Aug; 112(4):E272. PubMed ID: 23879911 [No Abstract] [Full Text] [Related]
13. Can prostate specific antigen derivatives reduce the frequency of unnecessary prostate biopsies? Klein EA J Urol; 1996 Aug; 156(2 Pt 1):443-4. PubMed ID: 8683698 [No Abstract] [Full Text] [Related]
15. The role of ultrasound in prostate cancer detection in patients with an elevated prostate specific antigen level but no prostatic nodule. Sanders RC Md Med J; 1993 Oct; 42(10):1007-11. PubMed ID: 7505045 [TBL] [Abstract][Full Text] [Related]
17. Editorial comment to association of prostate-specific antigen doubling time and cancer in men undergoing repeat prostate biopsy. Shimbo M Int J Urol; 2012 Aug; 19(8):747-8. PubMed ID: 22651131 [No Abstract] [Full Text] [Related]
19. Re: Billis et al.: Does the type of prostatic atrophy influence the association of extent of atrophy in needle biopsies and serum prostate-specific antigen levels? (Urology 2009;74:1111-1115). Papatsoris A; Albanis S; Deliveliotis C Urology; 2010 May; 75(5):1239; author reply 1240. PubMed ID: 20451754 [No Abstract] [Full Text] [Related]
20. Multilocular cystadenoma and cystadenocarcinoma of the prostate. Tuziak T; Spiess PE; Abrahams NA; Wrona A; Tu SM; Czerniak B Urol Oncol; 2007; 25(1):19-25. PubMed ID: 17208134 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]